Patents Assigned to S. M. Discovery Group Inc.
  • Patent number: 11730820
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: August 22, 2023
    Assignee: S. M. Discovery Group Inc.
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • Publication number: 20210290773
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: April 2, 2021
    Publication date: September 23, 2021
    Applicant: S. M. Discovery Group Inc.
    Inventors: Seyed Moien MOGHIMI, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • Patent number: 11000599
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: May 11, 2021
    Assignee: S. M. Discovery Group Inc.
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar